Tuberculous enteritis after intravesical Bacillus Calmette-Guerin therapy: A case of mistaken identity

Journal of Urology

Volumn 159, Issue 6, 1998, Pages 2091-2092

  Nemoto, Ryosuke ^a   Nakamura, Isao ^a   Honjyo, Ichiro ^a   Takahashi, Mitsuyoshi ^a   Abe, Chiyoji ^a  

^a NONE

Author keywords

BCG vaccine; Bladder; Mycobacterium bovis; Tuberculosis

Indexed keywords

BCG VACCINE;

AGED; ARTICLE; BACTERIUM ISOLATE; BLADDER CARCINOMA; CARCINOMA IN SITU; CASE REPORT; ENTERITIS; HUMAN; HUMAN TISSUE; INTESTINE TUBERCULOSIS; INTRAVESICAL DRUG ADMINISTRATION; MALE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPECIES DIFFERENTIATION;

EID: 0032426957     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63264-6     Document Type: Article

References (3)

1. Morales, A., Eidinger, D. and Bruce, A. W.: Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J. Urol., 116: 180, 1976.
2. Takahashi, M., Kazumi, Y., Fukasawa, Y., Hirano, K., Mori, T., Dale, J. W. and Abe, C.: Restriction fragment length polymorphism analysis of epidemiologically related mycobacterium tuberculosis isolates. Microbiol. Immunol., 37: 289, 1993.
3. Fishman, J. R., Walton, D. T., Flynn, N. M., Benson, D. R. and White, R. W.: Tuberculous spondylitis as a complication of intravesical bacillus Calmette-Guerin therapy. J. Urol., 149: 584, 1993.